Table 2.

Summary of the frequency of PNH clones detection in patients with IBMFS according to previous studies

StudyDisease (n)Patients with IBMFS who have a PNH cloneCutoff valueYear
Keller et al SDS (3), SDS likely (16), SDS possible (7) 0/26 Red cells >1.0%  
Neutrophils >1.0%  
DeZern et al DC (9), FA (4), DBA (2), SDS (3), c-MPL (2) 0/20 0.1% 2000-2008 
0.01% 2009-2014 
Shah et al DC (3), FA (2), DBA (1), Others (3) 0/9 Granulocytes >1.0% 2010-2018 
Erythrocytes >1.0% 2010-2018 
Granulocytes >0.05% 2018-2020 
Monocytes >0.3% 2018-2020 
Erythrocytes >0.01% 2018-2020 
Our data DC (8), FA (9), DBA (3), SDS (1) 9/21 Granulocytes >0.020%  
Erythrocytes >0.037%  
StudyDisease (n)Patients with IBMFS who have a PNH cloneCutoff valueYear
Keller et al SDS (3), SDS likely (16), SDS possible (7) 0/26 Red cells >1.0%  
Neutrophils >1.0%  
DeZern et al DC (9), FA (4), DBA (2), SDS (3), c-MPL (2) 0/20 0.1% 2000-2008 
0.01% 2009-2014 
Shah et al DC (3), FA (2), DBA (1), Others (3) 0/9 Granulocytes >1.0% 2010-2018 
Erythrocytes >1.0% 2010-2018 
Granulocytes >0.05% 2018-2020 
Monocytes >0.3% 2018-2020 
Erythrocytes >0.01% 2018-2020 
Our data DC (8), FA (9), DBA (3), SDS (1) 9/21 Granulocytes >0.020%  
Erythrocytes >0.037%  

DBA, Diamond–Blackfan anemia.

Close Modal

or Create an Account

Close Modal
Close Modal